Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
01/02/2013 | CN101422596B Preserved snake gall orange peel oral liquid and quality control method thereof |
01/02/2013 | CN101410124B Thioredoxin production promoting agent |
01/02/2013 | CN101347459B Medicine for treating cancer |
01/02/2013 | CN101298478B Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of hla |
01/01/2013 | US8343761 Methods of generating and using antibody-producing cells |
01/01/2013 | US8343536 natural, bioremodelable material includes a biocidal bismuth thiol agent and/or one or more other biofilm-inhibiting or wound healing agents; hernia repair device |
01/01/2013 | US8343518 Preservation of bioactive materials by freeze dried foam |
01/01/2013 | US8343485 Compositions and methods of vascular injury repair |
01/01/2013 | US8343484 Methods for increasing lactose and fructose digestion |
01/01/2013 | US8343483 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
01/01/2013 | US8343481 Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cells |
01/01/2013 | US8343479 Using hematopoietic stem cells to restore functional and structural integrity to damaged myocardium; tissue engineering; tissue repair; regenerative medicine |
12/27/2012 | WO2012176796A1 Method for amplifying nk cells |
12/27/2012 | WO2012175797A1 In vitro cardiovascular model |
12/27/2012 | WO2012175749A1 Delivery of viral agents |
12/27/2012 | WO2012175410A1 Conditional knockout mutants of sortilin-like receptor in apicomplexan parasites and uses thereof |
12/27/2012 | WO2012149468A3 Instruments and methods for the implantation of cell-seeded substrates |
12/27/2012 | WO2012129375A3 Vaccination of sex reversed hybrid tilapia (oreochromis niloticus x o. aureus) with an inactivated vibrio vulnificus vaccine |
12/27/2012 | WO2012125007A3 Methods and compositions for the treatment, prevention, and alleviation of bone and cartilage diseases or injuries and hair loss |
12/27/2012 | WO2012124978A3 Pharmaceutical composition for treating ischemic diseases, containing conditioned medium obtained through three-dimensional cell culture as active ingredient |
12/27/2012 | WO2012099507A3 Biopreparation balis for the prophylaxis and treatment of infectious diseases |
12/27/2012 | WO2012083900A3 Method for preparing biodegradable membranes for soft tissue regeneration |
12/27/2012 | WO2012052565A9 A polymeric nanoparticle |
12/27/2012 | WO2009142472A3 Bifidobacteria that produces folic acid, food composition and use of said bifidobacteria |
12/27/2012 | US20120330423 Engineered Scaffolds for Intervertebral Disc Repair and Regeneration and for Articulating Joint Repair and Regeneration |
12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
12/27/2012 | US20120329886 Use of periostin as a novel biomarker |
12/27/2012 | US20120329733 Methods and products related to metabolic interactions in disease |
12/27/2012 | US20120329714 Prolactin Induced Increase in Neural Stem Cell Numbers |
12/27/2012 | US20120329052 Identification of a dna variant associated with adult type hypolactasia |
12/27/2012 | US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor |
12/27/2012 | US20120328700 Methods and compositions for regenerating connective tissue |
12/27/2012 | US20120328699 Method and composition for treatment of skeletal dysplasias |
12/27/2012 | US20120328690 Amniotic Membrane Preparations and Purified Compositions and Anti-Inflammation Methods |
12/27/2012 | US20120328678 Hydrogel Networks Having Living Cells Encapsulated Therein |
12/27/2012 | US20120328673 Dendritic and hyperbranched polymers for cellular encapsulation and functionalization |
12/27/2012 | US20120328662 Composition for inhibiting tumor cell proliferation |
12/27/2012 | US20120328615 Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders |
12/27/2012 | US20120328609 Modulation of Axon Degeneration |
12/27/2012 | US20120328600 Injection of fibrin sealant using reconstituted components in spinal applications |
12/27/2012 | US20120328587 Method for Activating Natural Killer Cells by Tumor Cell Preparation In Vitro |
12/27/2012 | US20120328586 Methods and means for protecting the skin against pathogenic microorganisms |
12/27/2012 | US20120328585 Nutritional Composition Having Prebiotic |
12/27/2012 | US20120328584 Biological Pacemaker |
12/27/2012 | US20120328583 Treatment of pain using placental stem cells |
12/27/2012 | US20120328582 Primate Embryonic Stem Cells |
12/27/2012 | US20120328581 Tissue repair |
12/27/2012 | US20120328580 Compounds that enhance atoh1 expression |
12/27/2012 | US20120328579 Human trophoblast stem cells and use thereof |
12/27/2012 | US20120328578 Primed stem cells and uses thereof to treat inflammatory conditions in joints |
12/27/2012 | US20120328576 Defined dose therapeutic phage |
12/27/2012 | US20120328575 Modified Oncolytic Viruses |
12/27/2012 | US20120328574 P38 inhibitors |
12/27/2012 | US20120328573 Composition for Maintaining Healthy Kidney Function |
12/27/2012 | US20120328572 Bacillus bacteria for use in treating and preventing infection in aquatic animals |
12/27/2012 | US20120328571 Method for Using a Bacillus Subtilis Strain for Prophylaxis and Treatment of Gastro-Intestinal Conditions |
12/27/2012 | US20120328563 Cd4+cd25+ regulatory t cells from human blood |
12/27/2012 | US20120328557 Adhesive cell tissue gels |
12/27/2012 | US20120328523 Polyhydroxyalkanoates for in vivo applications |
12/27/2012 | CA2840161A1 Method for amplifying nk cells |
12/27/2012 | CA2839558A1 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
12/27/2012 | CA2839554A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
12/27/2012 | CA2839201A1 Amplification enhancement of blood derived progenitor cells using a closed culture system |
12/27/2012 | CA2839052A1 In vitro cardiovascular model |
12/26/2012 | EP2537922A2 Cd49f promoting proliferation, multipotency and reprogramming of adult stem cells through pi3k/akt/gsk3 pathway |
12/26/2012 | EP2537523A1 Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents |
12/26/2012 | EP2537522A1 Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells |
12/26/2012 | EP2537416A1 Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes |
12/26/2012 | EP2537030A1 A pharmaceutical composition of killed cells with substantially retained immunogenicity |
12/26/2012 | EP2536827A1 Methods of manufacture of therapeutic products comprising vitalized placental dispersions |
12/26/2012 | EP2536826A1 Therapeutic products comprising vitalized placental dispersions |
12/26/2012 | EP2536825A1 Immunocompatible amniotic membrane products |
12/26/2012 | EP2536824A1 Immunocompatible chorionic membrane products |
12/26/2012 | EP2536823A1 Methods of manufacture of immunocompatible chorionic membrane products |
12/26/2012 | EP2536417A1 Methods of manufacture of immunocompatible amniotic membrane products |
12/26/2012 | EP2536416A1 Arginine-containing compositions and methods for treating red blood cells |
12/26/2012 | EP2536288A1 A novel boswellia low polar gum resin extract and its synergistic compositions |
12/26/2012 | CN202620279U Chinese herbal powder for treating kidney channel tissue diseases and packagage thereof |
12/26/2012 | CN202620249U Calcium ion powder capsule |
12/26/2012 | CN102844110A Substrate for ligand immobilization and method for producing same |
12/26/2012 | CN102844040A 内脏脂肪蓄积抑制剂 The visceral fat accumulation inhibitor |
12/26/2012 | CN102844039A Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field |
12/26/2012 | CN102844038A Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
12/26/2012 | CN102844037A Probiotic containing modules for tube feeding |
12/26/2012 | CN102844036A Methods and compositions for in vitro and in vivo chondrogenesis |
12/26/2012 | CN102839206A Preparation method for promoting self generation of human bone marrow hematopoietic stem cells |
12/26/2012 | CN102839136A Lactobacillus johnsonii, and preparation and application thereof |
12/26/2012 | CN102839108A Functional ginseng health care liquor and preparation method thereof |
12/26/2012 | CN102836422A Disease prevention and growth promotion magic drug |
12/26/2012 | CN102836421A Intestinal environment-improving agent |
12/26/2012 | CN102836416A Bionic enzymolysis preparation method of leech powder |
12/26/2012 | CN102836412A Chinese medicinal composition for treating idiopathic facial paralysis and preparation method thereof |
12/26/2012 | CN102836405A Medicament for treating encephaloma |
12/26/2012 | CN102836401A Traditional Chinese medicine for treating chronic gastritis with large-leaved zanthoxylum root |
12/26/2012 | CN102836400A Chinese medicinal preparation treating cold congelation and blood stasis type menorrhalgia |
12/26/2012 | CN102836398A Traditional Chinese drug preparation for treating amebic dysentery |
12/26/2012 | CN102836397A Traditional Chinese drug preparation for treating postpartum lochiorrhea |
12/26/2012 | CN102836395A Traditional Chinese medicine composition used for treating dysmenorrhea |
12/26/2012 | CN102836394A Burn and scald ointment composition and burn and scald ointment, and preparation method thereof |
12/26/2012 | CN102836393A Medicament for treating chronic nephritis through permeation and kidney-activating cell regeneration therapy |